Not exact matches
Human breast cancers can be classified according to their histological and molecular features into different subtypes, including
luminal, ERBB2 and basal - like
tumors.
«It was really surprizing to realize that oncogenic Pik3ca in basal cells induced the formation of
luminal tumours, while its expression in
luminal cells gave rise to heterogeneous and more aggressive
tumors including basal - like
tumors,» comments Alexandra Van Keymeulen, the first author of the paper.
The
luminal cells generally lead to more aggressive
tumors.
The team also looked at the levels of the TAZ gene in
tumors from women with either
luminal or basal
tumors.
Horvath and Tell identified 84 genes that are expressed differently in basal - like cancer
tumors as compared to
luminal cancer
tumors.
«We note that there are two subgroups of breast
tumors by epigenome: one which we have called Epi - Basal, characterized by loss of epigenetic marks causing breakage of chromosomes and the other that we have called Epi -
Luminal B, that presents epigenetic inactivation of genes that should protect us from cancer and these altered cells can no longer do it.»
Humans have an ortholog of the murine Nrk gene, and considering that the gene expression pattern in breast
tumor in Nrk mutant mice was similar to that in human
luminal B breast cancer, the findings of this study may lead to further understanding of the mechanisms of human breast cancer suppression and to advances in its diagnosis and therapy.
The Cancer Genome Atlas study encompasses more than 500 primary
tumors representing the four intrinsic subtypes of breast cancer:
Luminal A,
Luminal B, Her2 - enriched, and Basal - like.
Luminal A tumors are the most prevalent (44 % in this study), followed by luminal B
Luminal A
tumors are the most prevalent (44 % in this study), followed by
luminal B
luminal B (24 %).
ER - positive
tumors comprise two «intrinsic subtypes»:
Luminal A, which generally has a favorable prognosis, and
Luminal B, which generally has a worse prognosis.
(C and D) Effects of MELK knockdown on established
tumors arising from implantation of basal (C) or
luminal (D) breast cancer cells.
Remarkably, down - regulation of MELK led to a substantial regression of
tumors arising from BBC cells but had little effect on
tumors derived from
luminal cancer cells (Figure 7C, D, Figure 7 — figure supplement 1).
Consistent with this observation of MELK overexpression in BBC, we found that MELK expression in breast
tumors has a significant inverse correlation with the expression of
luminal markers, including estrogen and progesterone receptors (ER, PR)(Figure 2F, Figure 2 — figure supplement 1F).